Zydus Lifesciences Limited (BOM: 532321)
India
· Delayed Price · Currency is INR 985.70
+6.60 (0.67%)
At close: Dec 19, 2024
Zydus Lifesciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 213,961 | 195,474 | 172,374 | 151,099 | 144,035 | 142,531 | Upgrade
|
| Other Revenue | 874 | - | - | - | - | - | Upgrade
|
| Revenue | 214,835 | 195,474 | 172,374 | 151,099 | 144,035 | 142,531 | Upgrade
|
| Revenue Growth (YoY) | 14.42% | 13.40% | 14.08% | 4.90% | 1.06% | 8.26% | Upgrade
|
| Cost of Revenue | 63,030 | 63,937 | 64,707 | 56,857 | 49,434 | 50,804 | Upgrade
|
| Gross Profit | 151,805 | 131,537 | 107,667 | 94,242 | 94,601 | 91,727 | Upgrade
|
| Selling, General & Admin | 45,248 | 42,454 | 37,648 | 32,472 | 31,237 | 33,066 | Upgrade
|
| Other Operating Expenses | 44,232 | 36,047 | 34,263 | 29,873 | 29,299 | 30,666 | Upgrade
|
| Operating Expenses | 97,973 | 86,145 | 79,139 | 69,501 | 67,245 | 70,709 | Upgrade
|
| Operating Income | 53,832 | 45,392 | 28,528 | 24,741 | 27,356 | 21,018 | Upgrade
|
| Interest Expense | -745 | -440 | -1,255 | -1,144 | -1,559 | -3,236 | Upgrade
|
| Interest & Investment Income | 1,281 | 1,281 | 768 | 696 | 500 | 330 | Upgrade
|
| Earnings From Equity Investments | 1,145 | 1,184 | 946 | 462 | 474 | 288 | Upgrade
|
| Currency Exchange Gain (Loss) | 457 | 806 | 2,843 | 1,482 | -92 | -92 | Upgrade
|
| Other Non Operating Income (Expenses) | 403 | -11 | 251 | 622 | 61 | -6 | Upgrade
|
| EBT Excluding Unusual Items | 56,373 | 48,212 | 32,081 | 26,859 | 26,740 | 18,302 | Upgrade
|
| Merger & Restructuring Charges | - | -177 | -101 | - | - | -442 | Upgrade
|
| Impairment of Goodwill | - | - | -5,941 | - | - | -454 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,385 | 1,385 | 596 | 874 | -187 | 725 | Upgrade
|
| Gain (Loss) on Sale of Assets | 134 | 134 | 208 | -17 | -36 | -147 | Upgrade
|
| Asset Writedown | - | - | - | - | -731 | -2,742 | Upgrade
|
| Other Unusual Items | -316 | -281 | - | 1,127 | -1,320 | - | Upgrade
|
| Pretax Income | 57,576 | 49,273 | 26,843 | 28,843 | 24,466 | 15,242 | Upgrade
|
| Income Tax Expense | 13,442 | 9,775 | 5,878 | 5,117 | 1,936 | 3,198 | Upgrade
|
| Earnings From Continuing Operations | 44,134 | 39,498 | 20,965 | 23,726 | 22,530 | 12,044 | Upgrade
|
| Earnings From Discontinued Operations | 253 | 230 | -46 | 22,457 | -680 | - | Upgrade
|
| Net Income to Company | 44,387 | 39,728 | 20,919 | 46,183 | 21,850 | 12,044 | Upgrade
|
| Minority Interest in Earnings | -1,357 | -1,133 | -1,316 | -1,310 | -514 | -278 | Upgrade
|
| Net Income | 43,030 | 38,595 | 19,603 | 44,873 | 21,336 | 11,766 | Upgrade
|
| Net Income to Common | 43,030 | 38,595 | 19,603 | 44,873 | 21,336 | 11,766 | Upgrade
|
| Net Income Growth | 53.29% | 96.88% | -56.31% | 110.32% | 81.34% | -36.36% | Upgrade
|
| Shares Outstanding (Basic) | 1,009 | 1,012 | 1,016 | 1,024 | 1,024 | 1,024 | Upgrade
|
| Shares Outstanding (Diluted) | 1,009 | 1,012 | 1,016 | 1,024 | 1,024 | 1,024 | Upgrade
|
| Shares Change (YoY) | -0.31% | -0.37% | -0.79% | - | - | - | Upgrade
|
| EPS (Basic) | 42.65 | 38.14 | 19.30 | 43.83 | 20.84 | 11.49 | Upgrade
|
| EPS (Diluted) | 42.65 | 38.14 | 19.30 | 43.83 | 20.84 | 11.49 | Upgrade
|
| EPS Growth | 53.76% | 97.61% | -55.97% | 110.32% | 81.34% | -36.36% | Upgrade
|
| Free Cash Flow | 31,783 | 23,213 | 16,579 | 9,019 | 24,399 | 20,274 | Upgrade
|
| Free Cash Flow Per Share | 31.50 | 22.94 | 16.32 | 8.81 | 23.83 | 19.80 | Upgrade
|
| Dividend Per Share | - | 3.000 | 6.000 | 2.500 | 3.500 | 3.500 | Upgrade
|
| Dividend Growth | - | -50.00% | 140.00% | -28.57% | 0% | 0% | Upgrade
|
| Gross Margin | 70.66% | 67.29% | 62.46% | 62.37% | 65.68% | 64.36% | Upgrade
|
| Operating Margin | 25.06% | 23.22% | 16.55% | 16.37% | 18.99% | 14.75% | Upgrade
|
| Profit Margin | 20.03% | 19.74% | 11.37% | 29.70% | 14.81% | 8.26% | Upgrade
|
| Free Cash Flow Margin | 14.79% | 11.88% | 9.62% | 5.97% | 16.94% | 14.22% | Upgrade
|
| EBITDA | 61,861 | 52,572 | 35,344 | 31,695 | 34,152 | 27,602 | Upgrade
|
| EBITDA Margin | 28.79% | 26.89% | 20.50% | 20.98% | 23.71% | 19.37% | Upgrade
|
| D&A For EBITDA | 8,029 | 7,180 | 6,816 | 6,954 | 6,796 | 6,584 | Upgrade
|
| EBIT | 53,832 | 45,392 | 28,528 | 24,741 | 27,356 | 21,018 | Upgrade
|
| EBIT Margin | 25.06% | 23.22% | 16.55% | 16.37% | 18.99% | 14.75% | Upgrade
|
| Effective Tax Rate | 23.35% | 19.84% | 21.90% | 17.74% | 7.91% | 20.98% | Upgrade
|
| Revenue as Reported | 218,090 | 198,315 | 174,240 | 153,346 | 144,491 | 143,670 | Upgrade
|
| Advertising Expenses | - | 2,957 | 2,573 | 2,514 | 2,543 | 2,459 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.